LIN28B and juvenile myelomonocytic leukemia: Aberrant LIN28B expression defines a poor prognosis subgroup in JMML (Helsmoortel et al., 2016a), where H19, a fetal oncogene (Matouk et al., 2014), is stabilized in the presence of LIN28B (Helsmoortel et al., 2016b).